ADAMTS13 and thrombotic thrombocytopenic purpura: The TTP diagnosis of the remaining 2 patients was clinical, based on the combination of MAHA and neurological manifestations, while ADAMTS13 and complement studies were lacking (Table 3) [34, 35].